Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | Zendy

S. Claiborne Johnston | Zendy; J. Donald Easton | Zendy; Mary Farrant | Zendy; William G. Barsan | Zendy; Robin Conwit | Zendy; Jordan J. Elm | Zendy; Anthony Kim | Zendy; Anne S. Lindblad | Zendy; Amy Yu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

Author(s) -

S. Claiborne Johnston,

J. Donald Easton,

Mary Farrant,

William G. Barsan,

Robin Conwit,

Jordan J. Elm,

Anthony Kim,

Anne S. Lindblad,

Amy Yu

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1800410

Subject(s) - clopidogrel , aspirin , medicine , cardiology , stroke (engine) , ischemic stroke , ischemia , mechanical engineering , engineering

Combination antiplatelet therapy with clopidogrel and aspirin may reduce the rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient ischemic attack (TIA). A trial of combination antiplatelet therapy in a Chinese population has shown a reduction in the risk of recurrent stroke. We tested this combination in an international population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research